In silico study: ADMET-driven pharmacokinetic profiling of antiviral compounds for pre-clinical screening framework of intranasal drug development
{{output}}
The ongoing emergence of respiratory viral pathogens, including novel variants and established threats such as influenza, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and Respiratory Syncytial Virus (RSV), continues to challenge global health ... ...
